We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+10.83%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$366M
AUM Growth
+$30.5M
Cap. Flow
-$2.1M
Cap. Flow %
-0.57%
Top 10 Hldgs %
28.66%
Holding
113
New
5
Increased
29
Reduced
34
Closed
1

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$980K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$628K
3
T icon
AT&T
T
+$566K
4
AAPL icon
Apple
AAPL
+$417K
5
WU icon
Western Union
WU
+$251K

Sector Composition

Rank Sector Weight
1 Technology 15.04%
2 Healthcare 13.93%
3 Industrials 11.85%
4 Consumer Staples 10.75%
5 Consumer Discretionary 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
51
iShares Core S&P Mid-Cap ETF
IJH
$124B
$2.67M 0.73%
47,175
+1,190
+3% +$66.2K
VB icon
52
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$2.65M 0.72%
11,712
USB icon
53
US Bancorp
USB
$99.6B
$2.56M 0.7%
45,541
BBH icon
54
VanEck Biotech ETF
BBH
$398M
$2.53M 0.69%
13,345
+50
+0.4% +$9.64K
CTAS icon
55
Cintas
CTAS
$81.6B
$2.45M 0.67%
22,120
WU icon
56
Western Union
WU
$2.04B
$2.42M 0.66%
135,473
-13,600
-9% -$251K
COP icon
57
ConocoPhillips
COP
$145B
$2.39M 0.65%
33,139
-225
-0.7% -$16.4K
HYG icon
58
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.35M 0.64%
27,067
+43
+0.2% +$3.73K
HYD icon
59
VanEck High Yield Muni ETF
HYD
$4.42B
$2.34M 0.64%
37,476
+2,285
+6% +$142K
IBB icon
60
iShares Biotechnology ETF
IBB
$9.18B
$2.13M 0.58%
13,986
+300
+2% +$46.4K
IAU icon
61
iShares Gold Trust
IAU
$62.9B
$1.87M 0.51%
53,838
GOOG icon
62
Alphabet (Google) Class C
GOOG
$4.56T
$1.86M 0.51%
12,860
-1,420
-10% -$205K
MGA icon
63
Magna International
MGA
$18.5B
$1.69M 0.46%
20,835
+4,010
+24% +$326K
JNJ icon
64
Johnson & Johnson
JNJ
$613B
$1.64M 0.45%
9,573
PFE icon
65
Pfizer
PFE
$143B
$1.41M 0.38%
23,832
-570
-2% -$28.2K
VEU icon
66
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$1.26M 0.34%
20,579
LLY icon
67
Eli Lilly
LLY
$1,000B
$1.24M 0.34%
4,473
SYK icon
68
Stryker
SYK
$131B
$1.16M 0.32%
4,354
CVX icon
69
Chevron
CVX
$385B
$1.05M 0.29%
8,963
PAYX icon
70
Paychex
PAYX
$41.9B
$1.05M 0.29%
7,675
-80
-1% -$9.89K
MMM icon
71
3M
MMM
$91.4B
$928K 0.25%
6,249
-203
-3% -$30.2K
ORCL icon
72
Oracle
ORCL
$409B
$890K 0.24%
10,211
DHR icon
73
Danaher
DHR
$139B
$752K 0.21%
2,581
CAT icon
74
Caterpillar
CAT
$382B
$732K 0.2%
3,542
VEA icon
75
Vanguard FTSE Developed Markets ETF
VEA
$230B
$646K 0.18%
12,663
+1,015
+9% +$52.1K

Similar funds

Boston Research & Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Research & Management held 113 positions worth $366M, up 9.1% from $336M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Research & Management's Q4 2021 filing shows 5 new, 29 increased, 34 reduced and 1 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 2,684 shares worth $287K. The largest sale was Microsoft, an estimated $980K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Research & Management's largest Q4 2021 buy was iShares Core S&P Total US Stock Market ETF: 2,684 shares worth $287K.
  • Boston Research & Management added most to Magna International in Q4 2021, an estimated $326K increase.
  • Boston Research & Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $980K.
  • Boston Research & Management fully exited Texas Instruments in Q4 2021, selling an estimated $203K.
  • Boston Research & Management's ten largest holdings make up 29% of its $366M portfolio in Q4 2021.
  • Boston Research & Management opened 5 new positions and closed 1 in Q4 2021.
  • Boston Research & Management's portfolio value rose 9.1% quarter-over-quarter to $366M.

Based on Boston Research & Management's 13F filing for Q4 2021, filed 10 Feb 2022.